PepGen PEPG
NASDAQ PEPG
$2.26 -0.16 (-6.82%)
As of: Oct 1, 2026 · 3:09 PM EDT

PepGen (PEPG) Liabilities and Shareholders Equity (2021 - 2026)

Updated

PepGen's Liabilities and Shareholders Equity came in at $141.4 million for Q2 2026, up 38.3% from $102.24 million a year earlier but down 9.5% from the prior quarter.

Analysis

PepGen (PEPG) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

At the end of FY2025, PepGen's Liabilities and Shareholders Equity was $173.91 million, up 15.3% from FY2024.

  • Liabilities and Shareholders Equity carries a four-year compound annual growth rate of 4.9% (FY2021 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $150.88 million in FY2024 (+5.5%), $143.05 million in FY2023 (-34.2%), $217.44 million in FY2022 (+51.4%) and $143.64 million in FY2021.
  • The five-year range for quarterly Liabilities and Shareholders Equity is $102.24 million (Q2 2025) to $230.8 million (Q2 2022).
  • Year-over-year, Liabilities and Shareholders Equity has increased for four consecutive quarters, with growth averaging 1.4% over the last eight quarters.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q1 2023 (growth of 52.4%), and the weakest in Q2 2025 (a decline of 47.2%).
  • Business Quant data shows PEPG's Liabilities and Shareholders Equity at $156.3 million (Q1 2026), $173.91 million (Q4 2025) and $190.06 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 PepGen 167.61 Mn 167.61 Mn - 141.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 141.40 Mn
Mar 31, 2026 156.30 Mn
Dec 31, 2025 173.91 Mn
Sep 30, 2025 190.06 Mn
Jun 30, 2025 102.24 Mn
Mar 31, 2025 127.39 Mn
Dec 31, 2024 150.88 Mn
Sep 30, 2024 170.23 Mn
Jun 30, 2024 193.51 Mn
Mar 31, 2024 207.00 Mn
Dec 31, 2023 143.05 Mn
Sep 30, 2023 164.27 Mn
Jun 30, 2023 182.09 Mn
Mar 31, 2023 201.04 Mn
Dec 31, 2022 217.44 Mn
Sep 30, 2022 208.46 Mn
Jun 30, 2022 230.80 Mn
Mar 31, 2022 131.88 Mn
Dec 31, 2021 143.64 Mn
API Access

PepGen Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PEPG&period=max&api_key=YOUR_API_KEY